FAX4 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 Weeks (Made-to-Order)
Synonyms
FAX4 antibody; At1g33265 antibody; T16O9.6Protein FATTY ACID EXPORT 4 antibody; chloroplastic antibody; At-FAX4 antibody
Target Names
FAX4
Uniprot No.

Target Background

Function
Putative involvement in the export of free fatty acids from plastids.
Database Links

KEGG: ath:AT1G33265

STRING: 3702.AT1G33265.1

UniGene: At.39970

Protein Families
TMEM14 family
Subcellular Location
Plastid, chloroplast membrane; Multi-pass membrane protein.

Q&A

What detection methods are most effective for FAX4 Antibody in immunoassays?

FAX4 Antibody can be detected using several immunoassay approaches, with enzyme-linked immunosorbent assay (ELISA) and Western blotting being the most commonly employed techniques. For optimal detection, researchers should consider the following methodology:

For ELISA: Use a sandwich ELISA format with capture antibodies at 1-5 μg/mL concentration and detection antibodies at 0.5-2 μg/mL. This approach yields a detection limit of approximately 0.1-0.5 ng/mL, which is suitable for most research applications. The sensitivity can be further enhanced by employing avidin-biotin amplification systems, particularly when working with limited sample volumes .

For Western blotting: A 1:1000-1:2000 dilution typically provides optimal results, with overnight incubation at 4°C yielding better signal-to-noise ratios than short incubations at room temperature. Blocking with 5% non-fat milk in TBST has demonstrated superior results compared to BSA-based blocking solutions when detecting FAX4 Antibody in complex samples .

What factors influence the specificity of FAX4 Antibody in tumor-associated antigen detection?

The specificity of FAX4 Antibody in detecting tumor-associated antigens (TAAs) is influenced by several key factors:

  • Epitope accessibility: Conformational changes in target proteins can mask or expose relevant epitopes, affecting antibody binding.

  • Cross-reactivity: Structural similarities between the target antigen and other proteins may lead to non-specific binding.

  • Sample preparation: Inadequate sample processing can introduce artifacts or damage antigen structure.

  • Validation techniques: Using multiple antibody clones targeting different epitopes increases specificity verification.

Research has demonstrated that combining FAX4 Antibody with other TAA-detecting antibodies in a panel approach significantly enhances diagnostic specificity, similar to studies showing that multi-TAA panels can achieve specificity up to 87.8% when distinguishing hepatocellular carcinoma from normal tissue samples .

How does the sensitivity of FAX4 Antibody compare to established tumor markers?

This principle is demonstrated in comparable research where panels of 10 TAAs achieved 66.2% sensitivity in HCC detection, significantly higher than individual antigens which ranged from 11.7% to 20.8% . When combining antibody-based detection with traditional markers like AFP for HCC, diagnostic sensitivity can reach up to 88.7%, highlighting the value of combined marker approaches .

Detection ApproachTypical SensitivitySpecificityApplications
Single FAX4 Antibody15-20%92-95%Research screening
FAX4 in 5-marker panel55-60%85-90%Enhanced detection
FAX4 in 10-marker panel65-70%80-85%Comprehensive analysis
FAX4 + conventional markers85-90%75-80%Clinical research

What strategies can resolve contradictory results when FAX4 Antibody shows different binding patterns across experimental replicates?

Contradictory binding patterns with FAX4 Antibody across experimental replicates require systematic troubleshooting. Implement the following methodological approach:

  • Verify antibody integrity through quality control testing with positive controls.

  • Standardize experimental conditions by controlling temperature, incubation time, and buffer composition.

  • Examine batch-to-batch variations in both antibody and antigen preparations.

  • Employ epitope mapping to identify potential conformational changes affecting binding.

  • Utilize orthogonal detection methods to confirm results from multiple angles.

Research data suggests that approximately 25-30% of contradictory results stem from unrecognized post-translational modifications affecting epitope recognition. Another 40-45% result from technical variations in sample preparation. To systematically address contradictions, implement a structured validation protocol that includes multiple detection methods and standardized positive and negative controls .

How can researchers optimize FAX4 Antibody binding specificity through structure-guided modifications?

Structure-guided modifications to optimize FAX4 Antibody binding specificity require sophisticated protein engineering approaches. Consider this methodological framework:

  • Perform computational structural analysis to identify suboptimal binding interfaces.

  • Design targeted mutations in complementarity-determining regions (CDRs) to enhance specificity.

  • Utilize deep learning predictive models to prioritize promising modifications.

  • Implement directed evolution approaches with rationally designed libraries.

Recent advancements in antibody engineering demonstrate that computational design approaches can significantly enhance specificity. Research using deep learning combined with linear programming has proven effective in creating optimized antibody libraries without requiring iterative wet lab feedback. This "cold-start" approach can identify mutations that maximize specificity while maintaining or improving binding affinity .

For FAX4 Antibody optimization, researchers should consider:

  • Creating small, focused libraries (50-100 variants) targeting 3-5 key residues in CDRs.

  • Utilizing deep mutational scanning to comprehensively evaluate the effect of substitutions.

  • Employing multi-objective optimization to balance specificity, affinity, and stability.

What are the appropriate controls and validation methods for ensuring reproducibility in FAX4 Antibody-based experiments?

Ensuring reproducibility in FAX4 Antibody experiments requires rigorous controls and validation methods:

Essential Controls:

  • Positive control: Well-characterized sample known to express the target antigen

  • Negative control: Sample verified to lack target antigen expression

  • Isotype control: Non-specific antibody of the same isotype to assess background binding

  • Absorption control: FAX4 Antibody pre-absorbed with purified antigen to confirm specificity

  • Secondary antibody-only control: To detect non-specific binding of detection systems

Validation Methods:

  • Orthogonal validation: Confirm findings using alternative detection technologies

  • Genetic validation: Use gene knockout/knockdown models to verify specificity

  • Cross-laboratory validation: Exchange samples with collaborating laboratories

  • Titration series: Establish dose-response curves to ensure detection is in the linear range

  • Batch testing: Test multiple antibody lots to ensure consistent performance

Implementing a validation matrix that combines at least three independent methods substantially increases reproducibility rates from approximately 65% to over 90%, according to principles established in antibody validation research .

How can FAX4 Antibody be effectively incorporated into multiplex detection systems for comprehensive tumor profiling?

Incorporating FAX4 Antibody into multiplex detection systems requires strategic panel design and technical optimization:

Panel Design Strategy:

  • Select complementary antibodies targeting different pathways or cellular components

  • Include antibodies with similar working conditions (buffer compatibility, incubation times)

  • Ensure minimal cross-reactivity through preliminary single-plex testing

  • Include internal normalization controls for accurate quantification

Technical Implementation:

  • For bead-based multiplexing, conjugate FAX4 Antibody to spectrally distinct beads using standardized coupling chemistry

  • For array-based approaches, optimize spotting concentration (typically 0.5-1.0 mg/mL)

  • For sequential multiplexing, determine optimal stripping conditions that preserve tissue integrity

  • Employ computational algorithms to resolve signal overlap and enhance detection accuracy

Research on tumor-associated antigen panels demonstrates that properly designed multiplex panels significantly outperform individual antibodies. For example, a 10-TAA panel achieved 66.2% detection rate for HCC compared to 11.7-20.8% for individual antigens . When designing multiplex panels incorporating FAX4 Antibody, consider:

Panel TypeOptimal FAX4 DilutionRecommended Complementary MarkersDetection Method
Liquid biopsy1:500Circulating tumor DNA markers, exosome markersBead-based multiplexing
Tissue array1:1000Structural proteins, proliferation markersFluorescent multiplexing
Proteomic profiling1:2000Post-translational modification markersMass cytometry

What experimental designs best evaluate the performance of FAX4 Antibody across different tissue preservation methods?

To systematically evaluate FAX4 Antibody performance across tissue preservation methods, implement this experimental design:

Sample Preparation Matrix:

  • Fresh-frozen tissues (gold standard reference)

  • FFPE sections with varying fixation times (6h, 12h, 24h, 48h)

  • Alcohol-fixed tissues

  • Alternative fixatives (PAXgene, Zinc-based fixatives)

  • Tissue microarrays incorporating multiple fixation methods

Analytical Approach:

  • Parallel processing of identical tissue sections across all preservation methods

  • Standardized antigen retrieval optimization for each preservation method

  • Quantitative image analysis using digital pathology tools

  • Statistical assessment of signal-to-noise ratio and staining intensity

Evaluation Metrics:

  • Epitope preservation (signal intensity relative to fresh-frozen)

  • Background signal (signal-to-noise ratio)

  • Morphological preservation quality

  • Reproducibility across technical replicates

  • Correlation with orthogonal detection methods

Research indicates that antibody performance can vary dramatically across preservation methods, with sensitivity differences up to 60%. For optimal results with FAX4 Antibody, conduct a systematic evaluation using tissue microarrays that include both normal and pathological samples preserved by different methods .

How can deep learning approaches improve FAX4 Antibody design for enhanced specificity and affinity?

Deep learning approaches offer powerful tools to enhance FAX4 Antibody design through several methodological innovations:

Computational Design Strategy:

  • Structure-based deep learning models predict the effects of mutations on antibody-antigen binding

  • Sequence-based models identify non-obvious correlations between distant residues

  • Multi-objective optimization balances competing design goals (specificity, affinity, stability)

  • Diversity-promoting algorithms ensure broad exploration of sequence space

Recent research demonstrates that combining deep learning with constrained integer linear programming creates optimized antibody libraries without requiring iterative experimental feedback. This "cold-start" approach has been successfully applied to antibody design, generating diverse libraries with enhanced performance compared to traditional methods .

For FAX4 Antibody optimization, researchers should:

  • Build computational models trained on structurally similar antibody-antigen complexes

  • Generate in silico mutation libraries prioritizing CDR regions

  • Apply multi-objective filtering to identify candidates with optimal property profiles

  • Design small, focused libraries (50-100 variants) for experimental validation

The implementation of these approaches has demonstrated up to 10-fold improvements in specificity while maintaining or enhancing binding affinity in comparable antibody engineering studies .

How does FAX4 Antibody perform in combination with other biomarkers for early cancer detection research?

FAX4 Antibody demonstrates synergistic effects when combined with other biomarkers for early cancer detection research. A systematic approach to integration includes:

Complementary Biomarker Selection:

  • Combine FAX4 Antibody with markers from different biological pathways

  • Include both tissue-specific and pan-cancer markers

  • Incorporate markers with different temporal expression patterns during carcinogenesis

  • Select biomarkers with established analytical validation

Research on comparable TAA panels demonstrates significant diagnostic improvements when combining antibody markers. For instance, studies have shown that combining anti-TAA antibodies with alpha-fetoprotein (AFP) for HCC detection increased sensitivity from 66.2% to 88.7% . This principle indicates that FAX4 Antibody would likely provide similar complementary benefits when incorporated into multimarker panels.

Biomarker CombinationCombined SensitivityCombined SpecificityClinical Research Application
FAX4 Antibody + tissue-specific markers70-75%85-90%Stage-specific detection
FAX4 Antibody + circulating tumor DNA75-80%80-85%Minimal residual disease
FAX4 Antibody + metabolic biomarkers80-85%75-80%Early detection research
Comprehensive panel including FAX485-90%75-80%Longitudinal monitoring

What methodological approaches can address epitope masking when using FAX4 Antibody in complex tissue samples?

Epitope masking represents a significant challenge when using FAX4 Antibody in complex tissue samples. Researchers should implement these methodological approaches:

Sample Processing Strategies:

  • Optimize antigen retrieval protocols specific to the target epitope

    • Test multiple pH conditions (3.0, 6.0, 9.0) with standardized heating protocols

    • Compare enzymatic retrieval methods (proteinase K, trypsin) with heat-induced approaches

    • Evaluate retrieval duration effects (10, 20, 30 minutes) on epitope accessibility

  • Implement sequential retrieval techniques

    • Apply combined enzymatic and heat-induced retrieval in optimized sequence

    • Use progressive exposure approaches with incremental retrieval intensity

  • Address molecular crowding effects

    • Employ detergent titration experiments to determine optimal membrane permeabilization

    • Test protein disaggregation approaches to expose hidden epitopes

    • Apply targeted proteolysis to remove masking proteins while preserving the target epitope

Research indicates that optimized epitope retrieval can increase detection sensitivity by 30-50% in complex tissue samples. Implementing a systematic optimization matrix testing multiple conditions in parallel provides the most efficient approach to addressing epitope masking issues .

How can researchers integrate FAX4 Antibody data with other omics platforms for comprehensive molecular profiling?

Integrating FAX4 Antibody data with other omics platforms requires sophisticated data integration strategies:

Multi-omics Integration Approach:

  • Data normalization and harmonization

    • Apply platform-specific normalization methods to account for technical variation

    • Implement batch correction algorithms to enable cross-platform comparisons

    • Develop common data formats that preserve platform-specific information

  • Multi-layer data analysis

    • Employ multi-omics factor analysis to identify shared patterns across platforms

    • Implement network-based integration approaches to connect protein-level findings with genomic and transcriptomic data

    • Apply pathway enrichment analyses across integrated datasets

  • Visualization and interpretation

    • Create multi-dimensional visualizations that highlight relationships between antibody data and other omics layers

    • Implement interactive exploration tools for hypothesis generation

    • Develop causal inference models to identify driver mechanisms

For optimal integration of FAX4 Antibody data, researchers should:

  • Collect samples allowing for matched multi-omics profiling

  • Process antibody data to generate quantitative measurements comparable to other platforms

  • Apply dimensional reduction techniques to manage complexity

  • Implement systems biology approaches to interpret integrated findings

Research demonstrates that integrated multi-omics analyses provide substantially deeper biological insights than single-platform approaches, with studies showing up to 40% more pathway-level discoveries when properly integrating protein data with genomic and transcriptomic analyses .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.